Literature DB >> 17477479

Outcome measures in psoriatic arthritis.

Dafna D Gladman1, Philip J Mease, Paul Healy, Philip S Helliwell, Oliver Fitzgerald, Alberto Cauli, Ennio Lubrano, Gerald G Krueger, Désirée van der Heijde, Douglas J Veale, Arthur Kavanaugh, Peter Nash, Christopher Ritchlin, William Taylor, Vibeke Strand.   

Abstract

Psoriatic arthritis (PsA), an inflammatory arthritis associated with psoriasis usually seronegative for rheumatoid factor, has emerged as a more common and severe disease than previously appreciated. The disease is multifaceted. Thus the assessment of PsA requires attention to peripheral joint involvement, axial disease, dactylitis, and enthesitis, as well as the skin manifestations. In addition, the assessment of patient reported features such as patient assessment of disease activity, pain, fatigue, quality of life, and the new concept of participation are important. The assessment of damage and the assessment of tissue histology are also important outcome measures. This article summarizes these features of PsA as well as current knowledge on the instruments available for the assessment of these domains.

Entities:  

Mesh:

Year:  2007        PMID: 17477479

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  26 in total

Review 1.  Treatment algorithms for early psoriatic arthritis: do they depend on disease phenotype?

Authors:  William Tillett; Neil McHugh
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

2.  Is remission a more realistic goal in psoriatic arthritis?

Authors:  Tajvur P Saber; Ursula Fearon; Douglas J Veale
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-02       Impact factor: 5.346

3.  Density, structure, and strength of the distal radius in patients with psoriatic arthritis: the role of inflammation and cardiovascular risk factors.

Authors:  T Y Zhu; J F Griffith; L Qin; V W Y Hung; T-N Fong; S-K Au; A W Kwok; P-C Leung; E K Li; L-S Tam
Journal:  Osteoporos Int       Date:  2014-08-27       Impact factor: 4.507

4.  A resistance exercise program improves functional capacity of patients with psoriatic arthritis: a randomized controlled trial.

Authors:  Diego Roger-Silva; Jamil Natour; Emilia Moreira; Fabio Jennings
Journal:  Clin Rheumatol       Date:  2017-11-28       Impact factor: 2.980

5.  Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?

Authors:  Gamze Kilic; Erkan Kilic; Kemal Nas; Ayhan Kamanlı; İbrahim Tekeoglu
Journal:  Rheumatol Int       Date:  2018-11-13       Impact factor: 2.631

Review 6.  Management of psoriatic arthritis from the view of the dermatologist.

Authors:  Caroline A Chang; Alice B Gottlieb; Paul F Lizzul
Journal:  Nat Rev Rheumatol       Date:  2011-09-13       Impact factor: 20.543

Review 7.  Axial psoriatic arthritis: an intriguing clinical entity or a subset of an intriguing disease?

Authors:  Ennio Lubrano; Antonio Spadaro
Journal:  Clin Rheumatol       Date:  2012-05-03       Impact factor: 2.980

Review 8.  [Psoriatic arthritis. Treatment outcome parameters].

Authors:  E Märker-Hermann; F Behrens
Journal:  Z Rheumatol       Date:  2009-02       Impact factor: 1.372

9.  Remission in psoriatic arthritis: is it possible and how can it be predicted?

Authors:  Tajvur P Saber; C T Ng; Guillaume Renard; Bernadette M Lynch; Eliza Pontifex; Ceara A E Walsh; Alexia Grier; Marian Molloy; Barry Bresnihan; Oliver Fitzgerald; Ursula Fearon; Douglas J Veale
Journal:  Arthritis Res Ther       Date:  2010-05-18       Impact factor: 5.156

Review 10.  Treatment recommendations for psoriatic arthritis.

Authors:  C T Ritchlin; A Kavanaugh; D D Gladman; P J Mease; P Helliwell; W-H Boehncke; K de Vlam; D Fiorentino; O Fitzgerald; A B Gottlieb; N J McHugh; P Nash; A A Qureshi; E R Soriano; W J Taylor
Journal:  Ann Rheum Dis       Date:  2008-10-24       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.